医師の一分

アクセスカウンタ

zoom RSS 遺伝子組み換えサケに対する疑問/米国 FDA

<<   作成日時 : 2012/02/14 20:20   >>

驚いた ブログ気持玉 1 / トラックバック 0 / コメント 0

遺伝子組み換えサケに対する疑問
画像 米国の消費者グループがFDAに対して厳格な審査を要望している。問題となっているのはAquaBountyテクノロジーズのAquAdvantageサーモンで、他種の遺伝子を持ち通常の2倍の成長速度を持つことから、食品添加物の一種としてFDAに対して厳格な審査を求めている。
 遺伝子組み換えサケは、誤って野生に出た場合、他の魚に影響を与える可能性があり、また、乳癌、結腸癌、前立腺癌、肺癌に関連するホルモン値の増加がみられることが懸念されるという。
 承認された場合、米国で人が消費する最初の遺伝子組み換え動物となる。

----------------------------------------------------
Consumer groups want tougher probe of engineered salmon
http://www.reuters.com/article/2012/02/08/us-salmon-genetic-consumers-idUSTRE81702V20120208

WASHINGTON | Tue Feb 7, 2012 9:49pm EST
(Reuters) - Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

The fish at issue, AquaBounty Technologies' AquAdvantage salmon, is currently classified as a new animal drug for the purposes of FDA review.

The FDA considers any genetically altered animal a new animal drug for approval purposes. The petition calls for the salmon to be classified as a food additive instead, which would require a more rigorous FDA review.

AquaBounty is seeking U.S. approval to market its engineered Atlantic salmon, which contains a gene from another fish species, the Chinook salmon, to help it grow twice as fast as normal.

The consumer groups' petition says the way these salmon are created substantially alters their composition and nutritional value, and so they should be treated as a food additive. Under this standard, they said, the company's data would have to overwhelmingly prove AquAdvantage salmon are safe to eat.

The consumer groups - Food & Water Watch, Consumers Union, and the Center for Food Safety - said in a statement the "new animal drug" designation is insufficient to protect public health. The review process for food additives offers greater protection, they said.

AquaBounty had no comment on the petition.

The FDA did not comment specifically on the petition, but confirmed that the company's application for FDA approval for AquAdvantage salmon is under review, and that genetically engineered animals are evaluated under the new animal drug provisions of U.S. law.

AquaBounty has said in the past that it sees these genetically modified salmon as a potential solution to environmental concerns associated with salmon aquaculture, and discounted fears they might accidentally escape into the wild and affect other fish.

However, Food & Water Watch Executive Director Wenonah Hauter said the company's own study showed that genetically engineered salmon may contain increased levels of a hormone linked to breast, colon, prostate and lung cancer.

The petitioners said a proper review would require genetically engineered salmon to go through comprehensive toxicological studies to ensure the fish are safe to consume and properly labeled.

If approved, AquAdvantage would be the first genetically altered animal for human consumption in the United States.

Genetically modified vegetables such as corn have long been on the U.S. market, and the FDA allows modified animals as pets or to help produce biologic medicines.

There is no timeline for an FDA decision. As a matter of policy, the FDA does not comment on citizen petitions.

(Reporting By Deborah Zabarenko, Environment Correspondent; Editing by Todd Eastham)

This story updates clarifies the sixth paragraph reference to new animal drug

テーマ

関連テーマ 一覧


月別リンク

ブログ気持玉

クリックして気持ちを伝えよう!
ログインしてクリックすれば、自分のブログへのリンクが付きます。
→ログインへ
気持玉数 : 1
驚いた

トラックバック(0件)

タイトル (本文) ブログ名/日時

トラックバック用URL help


自分のブログにトラックバック記事作成(会員用) help

タイトル
本 文

コメント(0件)

内 容 ニックネーム/日時

コメントする help

ニックネーム
本 文
遺伝子組み換えサケに対する疑問/米国 FDA 医師の一分/BIGLOBEウェブリブログ
文字サイズ:       閉じる